A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...

D-Wave Quantum’s QBTS standout growth catalyst this quarter is the successful launch and commercial deployment of its next-generation Advantage2 quantum annealer. In the last-reported quarter, the ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

Vor Bio is licensing global rights a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

The first quarter of 2025 saw a rise in volatility as markets adjust to abrupt policy changes in the US. Stock selection in ...

The ECB should abandon targeting headline inflation and focus instead on price growth in discretionary spending to protect ...

Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

Many teens (and adults, for that matter) passed the long hours in the summer of 2020 playing video games. And now, they could ...

Visa (NYSE:V) and Mastercard (NYSE:MA)’s default multilateral interchange fees charged to retailers violate competition law, ...

Despite facing a projected $1 billion impact from new tariffs, Nike’s management outlined comprehensive mitigation strategies that have boosted investor confidence and sparked renewed optimism about ...

AstraZeneca Share Price – Track LIVE BSE/NSE stock prices of AstraZeneca with insights on performance, fundamentals, market cap, shareholding, financials, company profile, balance sheet, annual and ...